Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.
Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, Runnebaum IB. Wang-Gohrke S, et al. Among authors: vesprini d. Br J Cancer. 1999 Sep;81(1):179-83. doi: 10.1038/sj.bjc.6690669. Br J Cancer. 1999. PMID: 10487631 Free PMC article.
Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
Bisgaard ALH, Keesman R, van Lier ALHMW, Coolens C, van Houdt PJ, Tree A, Wetscherek A, Romesser PB, Tyagi N, Lo Russo M, Habrich J, Vesprini D, Lau AZ, Mook S, Chung P, Kerkmeijer LGW, Gouw ZAR, Lorenzen EL, van der Heide UA, Schytte T, Brink C, Mahmood F. Bisgaard ALH, et al. Among authors: vesprini d. Radiother Oncol. 2023 Sep;186:109803. doi: 10.1016/j.radonc.2023.109803. Epub 2023 Jul 10. Radiother Oncol. 2023. PMID: 37437609 Free PMC article.
Elective Nodal Irradiation: Old Game, New SPORT.
Vesprini D, Pathmanathan A, Murthy V. Vesprini D, et al. Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):610-612. doi: 10.1016/j.ijrobp.2023.07.003. Int J Radiat Oncol Biol Phys. 2023. PMID: 37739608 No abstract available.
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial.
Ong WL, Cheung P, Chung H, Chu W, Detsky J, Liu S, Morton G, Szumacher E, Tseng CL, Vesprini D, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A. Ong WL, et al. Among authors: vesprini d. Radiother Oncol. 2023 Apr;181:109503. doi: 10.1016/j.radonc.2023.109503. Epub 2023 Feb 6. Radiother Oncol. 2023. PMID: 36754232 Clinical Trial.
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).
Glicksman RM, Loblaw A, Morton G, Vesprini D, Szumacher E, Chung HT, Chu W, Liu SK, Tseng CL, Correa R, Deabreu A, Mamedov A, Zhang L, Cheung P. Glicksman RM, et al. Among authors: vesprini d. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):100-109. doi: 10.1016/j.ijrobp.2023.11.006. Epub 2023 Nov 17. Int J Radiat Oncol Biol Phys. 2024. PMID: 37979707 Clinical Trial.
168 results